Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

BACKGROUND: The present study investigated the efficacy and safety of nivolumab in pre-treated patients with advanced NSCLC harbouring KRAS mutations. METHODS: Clinical data and KRAS mutational status were analysed in patients treated with nivolumab within the Italian Expanded Access Program. Object...

Descripción completa

Detalles Bibliográficos
Autores principales: Passiglia, Francesco, Cappuzzo, Federico, Alabiso, Oscar, Bettini, Anna Cecilia, Bidoli, Paolo, Chiari, Rita, Defferrari, Carlotta, Delmonte, Angelo, Finocchiaro, Giovanna, Francini, Guido, Gelsomino, Francesco, Giannarelli, Diana, Giordano, Monica, Illiano, Alfonso, Livi, Lorenzo, Martelli, Olga, Natoli, Clara, Puppo, Gianfranco, Ricevuto, Enrico, Roca, Elisa, Turci, Daniele, Galetta, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325128/
https://www.ncbi.nlm.nih.gov/pubmed/30377342
http://dx.doi.org/10.1038/s41416-018-0234-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325128/
https://www.ncbi.nlm.nih.gov/pubmed/30377342
http://dx.doi.org/10.1038/s41416-018-0234-3

Ejemplares similares